Overview
The Hematology Oncology Fellowship program’s mission at Cleveland Clinic in Florida is to train fellows to build a solid foundation in diagnosing and treating hematology and oncology disease processes. Cleveland Clinic in Florida Hematology Oncology staff physicians are committed to providing a comprehensive educational experience to the next generation of physician scientists. We aim to encourage our trainees to practice the art and science of hematology-oncology through compassionate patient care, and by contributing to its continuous improvement and development through cutting edge research.
Clinical experience is provided as a hematology and oncology consultant in both the outpatient and inpatient settings. The core clinical rotations include malignant hematology (both inpatient and outpatient rotations), disease specific oncology rotations including outpatient clinic exposure to patients diagnosed with various solid tumor malignancies. Core clinical rotations will also include exposure to benign hematology disorders and bone marrow transplant.
The core clinical rotations are designed to cover most of the areas identified below. Individual fellow experience is considered when determining rotations outside the core clinical rotations. Formal instruction is provided through the orientation conference series, weekly fellows’ conference, case-based conferences in hematology and oncology, journal club, board review, division conferences, teaching rounds (embedded in rotations), art of oncology lecture series, wet lab and multidisciplinary tumor boards. Competence is demonstrated through 360-degree evaluations, in training exam and board exams.
The Cleveland Clinic in Florida Hematology Oncology Fellowship program provides formal instruction, clinical experience and demonstrated competence in the prevention, evaluation and management of diagnosis, pathology, staging and management of neoplastic disorders of the:
- Lung
- Gastrointestinal tract (esophagus, stomach, colon, rectum, anus)
- Breast
- Pancreas
- Liver
- Testes
- Lymphoid organs
- Hematopoietic system
- Central nervous system
- Head and neck
- Thyroid and other endocrine organs, including MEN syndromes
- Skin, including melanoma
- Genitourinary tract
- Cancer family syndromes
- Gynecologic malignancies
Program
The Hematology/Oncology Fellowship program aims to utilize the expertise and experience of our Hematology/Oncology faculty and CCF resources to achieve the mission of preparing high-quality physicians. This will be achieved through the following goals:
- Clinical excellence and proficiency: Our program aims to provide clinical excellence and proficiency in the broad discipline of hematology and oncology, so fellows are prepared to provide the best care for the patients.
- Scholarly activities: Scholarly activities are achieved by requiring fellows to develop research projects that contribute to the body of knowledge in hematology and oncology.
- Professional integrity: This aim is achieved by emphasizing professionalism, ethical behavior, and adherence to high standards of medical practice as modelled by our clinical faculty.
- Inclusivity: Inclusivity is achieved by creating an environment of compassionate belonging where all are valued and respected.
- Well-being: Our program aims to promote fellow’s well-being and resilience, recognizing the importance of maintaining physical and mental health throughout training.
- Leadership: Our program aims to prepare fellows to assume leadership roles within the field of hematology and oncology, demonstrating a continual dedication to improving patient health and well-being.
Clinical rotation: Benign hematology
Fellows will be required to complete a one-month rotation in Benign Hematology as a PGY-4, PGY-5, and PGY-6. Fellows may complete up to two additional months as an elective during PGY-4 or PGY-5, and up to five months as an elective during PGY-6. The Bening Hematology rotations will provide a sophisticated and comprehensive experience in the diagnosis and management of benign hematological disorders, under the direct supervision of attending physicians specializing in Benign Hematology. Fellows gain clinical experience to diagnosis, treatment, and complications of benign hematological disorders.
Clinical rotation: Breast oncology
Fellows will be required to complete a one-month rotation as a PGY-4. Up to two additional months as a PGY-4 or PGY-5 and up to five months as a PGY-6 may be done as an elective. The Breast Oncology rotation will provide a sophisticated and comprehensive experience in the diagnosis and management of breast oncologic diseases, under the direct supervision of attending physicians specializing in breast oncology. Fellows will have exposure to biology, pathogenesis, diagnosis, treatment, and complications of early, locally advanced, or metastatic breast cancer.
Clinical rotation: Gastrointestinal (GI) oncology
Fellows will be required to complete a one-month rotation of GI Oncology. Up to three months as a PGY-4, up to two months as PGY-5, and up to four months as a PGY-6 may be completed. The GI Oncology rotation will provide a sophisticated and comprehensive experience in the diagnosis and management of gastrointestinal cancers, under the direct supervision of attending physicians specializing in gastrointestinal oncology. Fellows will have exposure to the biology, pathogenesis, diagnosis, treatment, and complications of early, locally advanced, or metastatic gastrointestinal cancer.
Clinical rotation: Genitourinary (GU) oncology
Fellows are required to complete a one-month rotation as a PGY-5 in Genitourinary Oncology. Fellows may complete up to two months as a PGY-4 and PGY-5 and up to five months as PGY-6 as an elective. The GU rotation will provide a sophisticated and comprehensive experience in the diagnosis and management of Genitourinary oncologic diseases, under the direct supervision of attending physicians specializing in Genitourinary Oncology. Fellows will have exposure to biology, pathogenesis, diagnosis, treatment, and complications of early, locally advanced, or metastatic Genitourinary cancer.
Clinical rotation: Gynecologic oncology
Fellows must complete a minimum of one month of a Gynecologic Oncology rotation. Fellows may complete up to two months as a PGY-4, up to five months as a PGY-5, and up to four months as a PGY-6. The Gynecologic Oncology rotations will provide a sophisticated and comprehensive experience in the diagnosis and management of Gynecologic oncologic diseases, under the direct supervision of attending physicians specializing in Gynecologic Oncology. Fellows will have exposure to the biology, pathogenesis, diagnosis, treatment, and complications of early, locally advanced, or metastatic Gynecologic cancers.
Clinical rotation: Malignant hematology
Fellows will be required to complete a one-month rotation of Malignant Hematology. Fellows may complete up to five months as PGY-4, up to five months as PGY-5, and up to four months as PGY-6. This rotation will provide a sophisticated and comprehensive experience in the diagnosis and management of Malignant hematological disorders, under the direct supervision of attending physicians specializing in Malignant Hematology. Fellows will have exposure to the biology, pathogenesis, diagnosis, treatment, and complications of Malignant hematological disorders. Procedures: Fellows will have the opportunity to perform or refer patients for the following procedures if indicated in their patients during the normal course of care or they will complete these procedures through an observational rotation in interventional radiology (thoracenteses, paracenteses, lesion biopsies, bone marrow biopsies.)
Clinical rotation: Sarcoma/melanoma/CNS (SMC) oncology
Fellows are required to complete a minimum of a one-month rotation of SMC Oncology. Fellows may complete up to two months as a PGY-4, up to five months as a PGY-5, and up to four months as a PGY-6. The SMC Oncology rotations will provide a sophisticated and comprehensive experience in the diagnosis and management of Sarcoma, Melanoma, and CNS tumors under the direct supervision of attending physicians. Fellows will have exposure to the biology, pathogenesis, diagnosis, treatment, and complications of early, locally advanced, or metastatic tumors.
Clinical rotation: Stem cell transplant and cellular therapy (TCT)
Fellows will complete two months of TCT rotations as a PGY-4, two months as a PGY-5, and up to two months as PGY-6 as an elective. TCT rotations will provide comprehensive exposure to the principles and practice of high dose therapies, and autologous and allogeneic hematopoietic stem cell transplantation, including the infectious disease complications and graft-versus-host disease and Cellular Therapy including Immune effector T cell Therapy. A critical spectrum of diseases seen during this rotation includes acute leukemias, chronic leukemias, non-Hodgkin’s lymphomas, Hodgkin’s disease, myelodysplastic syndrome, myeloproliferative disorders, multiple myeloma, and bone marrow failure conditions like aplastic anemia.
Clinical rotation: Thoracic head and neck oncology
Fellows will be required to complete a one-month rotation of Thoracic Head and Neck Oncology. Fellows may complete up to three months as PGY-4, up to two months as PGY-5, and up to four months of as PGY-6. This rotation will provide a sophisticated and comprehensive experience in the diagnosis and management of Thoracic, Head and Neck oncologic diseases, under the direct supervision of attending physicians specializing in Thoracic, Head and Neck oncology. Fellows will have exposure to the biology, pathogenesis, diagnosis, treatment, and complications of early, locally advanced, or metastatic Thoracic, Head and Neck cancers.
Benefits
Benefits information including salaries, insurance information and more, can be found by visiting the Graduate Medical Education Benefits page.
